Anticounterfeiting, Track and Trace Systems

Progress is being made, but work remains to be done. Brian Daleiden, vice president of marketing at TraceLink, discusses the state of the industry, as companies attempt to meet complex, and changing, global requirements.

With deadlines only a few years away, some companies have not started serialization programs, while others are taking a tactical, short-term approach, losing out on potential business benefits.

Platinum Press provides serialization-ready printed materials to apply final track-and-trace data onto packaged pharmaceutical products.

The Safe Chain Track and Trace System automates traceability for supply chain security.

Virtual pilot programs examine scenarios that may occur while implementing serialization requirements for the US Drug Supply Chain Security Act.

ReposiTrak signs agreement to pilot track and trace system in pharma.

The company is keen to show how new packaging technologies can incorporate patient-focused elements.

Virtual pilot programs that simulate scenarios can help the pharmaceutical industry address core issues in the implementation of serialization systems that comply with the US Drug Supply Chain Security Act.

FDA and industry support global framework and collaborations to secure the supply chain.

Sponsors and contract partners alike should not assume that upcoming US federal deadlines will be as elastic as California’s were.

Pharmacy associates say more education regarding the transactional requirements of DSCSA is needed.

Although full traceability is not required by law in the US until 2023, companies could benefit from implementing it now.

The Hapa 862, from Hapa AG, is a modular, CMYK/spot-color inkjet printing system for the in-line packaging printing of foils and labels.

Pharmaceutical Technology spoke with Tim Kearns, pharmaceutical and medical devices manager at Videojet.

Compliance with the new traceability requirements necessitates an understanding of how and when to begin implementing changes in an ever-evolving industry.

A complex and evolving set of regulations challenges drug manufacturers to understand and implement serialization requirements.

Pharmaceutical companies should take into consideration intellectual property protection when outsourcing the packaging of their products.

New rules for tracing drugs through the supply chain and policies for drug compounders change the regulatory landscape.

The agency is enlisting members of European pharmaceutical associations and industry representatives to participate in IDMP task force.

Manufacturers face new rules for tracing drugs through the supply chain and compounders face stricter standards.

CDMO Vetter announced the addition of a new flexible serialization service, introduced in response to stricter packaging regulations calling for drugs to be serialized as a means to fight counterfeits.

Stakeholders face challenges and benefits from a more secure pharmaceutical supply chain.

MG America's ACE-BT300 Coding and Verification Unit provides track-and-trace capabilities for bottles.

New identifiers and tracking requirements aim to block illegitimate products.

New identifiers and tracking requirements aim to block illegitimate products.

The international “Fight the Fakes” campaign will raise awareness about the dangers of counterfeit medicines.

The Drug Quality and Security Act creates national standards for serialization of drug products to protect against counterfeiting.

New weapons in the anticounterfeiting arsenal include authentication and labeling technologies.

Compounding, tracking legislation moves forward

Bills to regulate drug compounding and establish a national track and trace system face political and policy differences.